Biomerica
BMRA
10 hedge funds and large institutions have $152K invested in Biomerica in 2018 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
11% more funds holding
Funds holding: 9 → 10 (+1)
0.1% less ownership
Funds ownership: 0.22% → 0.12% (-0.1%)
74% less capital invested
Capital invested by funds: $576K → $152K (-$424K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Perritt Capital Management
Chicago,
Illinois
|
+$112K |
| 2 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$2.81K |
| 3 |
NFG
Next Financial Group
Houston,
Texas
|
+$967 |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$135 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$215K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$123K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$8K |
| 4 |
BlackRock
New York
|
-$989 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$360 |
BMRA Hedge Fund Activity: Q4 2018 in Review
10 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Biomerica (BMRA) for Q4 2018, worth a combined $152K — down 74% from $576K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new BMRA positions and 3 closed out — a net gain of 1 holder — while 0 added to existing stakes and 3 trimmed.
The largest buyer was Perritt Capital Management, opening a new position worth an estimated $112K. The largest seller was Vanguard Group, cutting an estimated $215K.
- 10 institutional investors held Biomerica (BMRA) as of Q4 2018, up from 9 in Q3 2018.
- Funds reported $152K of Biomerica stock for Q4 2018, down 74% quarter-over-quarter.
- 4 funds opened new Biomerica positions in Q4 2018 and 3 closed out, a net change of +1 holder.
- The largest Biomerica buyer in Q4 2018 was Perritt Capital Management, an estimated $112K added.
- The largest Biomerica seller in Q4 2018 was Vanguard Group, an estimated $215K sold.
Based on aggregated 13F filings for Q4 2018.